In this study, SARS-CoV-2 infected non-hospitalized patients hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization.
Our study, including a large sample of patients hospitalized with COVID-19 in Italy, shows HCQ use had a 30% reduction of overall in-hospital mortality.
HCQ use was associated with a 30% lower risk of death in COVID-19 hospitalized patients. Our data doesn’t discourage use of HCQ in inpatients with COVID-19.
This Multicenter Study shows that the risk of death is 30% lower for coronavirus patients treated with hydroxychloroquine.
Within two years, “17,000 people with AIDS died because Dr. Fauci insisted on not allowing even a statement considerating of the use” of the antibiotic.
Source: Murray Wiseman Authors: Scholz, Derwand, Zelenko A discussion of a retrospective study early risk-stratified treatment of Covid-19 outpatients with zinc plus low-dose hydroxychloroquine and
Source: Freshers Live Author: IANS A study in Belgium that went through the hospital data of 8,075 patients has found that low doses of hydroxychloroquine
Source: Craig Kelly The Hon. Craig Kelly MP, delivered a speech to Parliament on the current status of hydroxychloroquine restrictions in Australia. He referenced ‘late
